This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International
September 23-26, 2024
Hynes Convention CenterBoston, USA

Amir Hefni
CEO at Resolution Therapeutics


Amir is the CEO of Resolution Therapeutics, joining the company in Aug 2023 from Novartis where he was Global Head of Cell and Gene Therapy. Previously, he was a Global Asset Head in Oncology at Ipsen and spent most of his career at Bristol-Myers Squibb with roles across the US and Europe. Amir holds a BSc and PhD in Pharmacology from King’s College London and an MBA from Warwick Business School.

Agenda Sessions

  • Pioneering Macrophage Cell Therapy for transformative outcomes in Inflammatory Organ Disease